Institutional Ownership Changes (13F Filings) for Helius Medical Technologies (NASDAQ:HSDT)
- Current
Institutional Ownership
Percentage - 29.74%
- Number of
Institutional Buyers
(last 12 months) - 5
- Total
Institutional Inflows
(last 12 months) - $2.64 M
- Number of
Institutional Sellers
(last 12 months) - 5
- Total
Institutional Outflows
(last 12 months) - $385,811.21
Get HSDT Insider Trade Alerts
Want to know when executives and insiders are buying or selling Helius Medical Technologies stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.
Helius Medical Technologies Major Shareholders & Ownership History
(Data available from 1/1/2016 forward)

HSDT Institutional Ownership - Frequently Asked Questions
Who are the largest shareholders of HSDT shares?
During the previous two years, 15 institutional investors and hedge funds held shares of Helius Medical Technologies. The most heavily invested institutionals were AIGH Capital Management LLC ($1.30M), ACT Capital L.L.C. ($1.02M), Renaissance Technologies LLC ($0.54M), Kepos Capital LP ($0.52M), Worth Venture Partners LLC ($0.30M), Geode Capital Management LLC ($0.28M), and Altium Capital Management LP ($0.25M).Learn more on HSDT's institutional investors.
What percentage of Helius Medical Technologies stock is owned by institutional investors?
Which institutional investors have been buying Helius Medical Technologies stock?
Of the 13 institutional investors that purchased Helius Medical Technologies stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: AIGH Capital Management LLC ($0.25M), Kepos Capital LP ($0.10M), Rollins Financial ($100K), Renaissance Technologies LLC ($96.21K), Vanguard Group Inc. ($51.35K), Altium Capital Management LP ($48.86K), and Delta Investment Management LLC ($37.18K).
How much institutional buying is happening at Helius Medical Technologies?
Institutional investors have bought a total of 745,531 shares in the last 24 months. This purchase volume represents approximately $4.82M in transactions.
Which Helius Medical Technologies major shareholders have been selling company stock?
The following institutional investors have sold Helius Medical Technologies stock in the last 24 months: Rovida Advisors Inc. ($1.27M), Renaissance Technologies LLC ($1.10M), BlackRock Inc. ($0.10M), ACT Capital Management LLC ($35.35K), Vanguard Group Inc. ($24.89K), Delta Investment Management LLC ($12.50K), and Isthmus Partners LLC ($9K).
How much institutional selling is happening at Helius Medical Technologies?
Institutional investors have sold a total of 2,558,896 shares in the last 24 months. This volume of shares sold represents approximately $44.69M in transactions.